chr1-184795328-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052966.4(NIBAN1):c.2436G>T(p.Glu812Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000559 in 1,610,910 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052966.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIBAN1 | NM_052966.4 | c.2436G>T | p.Glu812Asp | missense_variant | 14/14 | ENST00000367511.4 | NP_443198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIBAN1 | ENST00000367511.4 | c.2436G>T | p.Glu812Asp | missense_variant | 14/14 | 1 | NM_052966.4 | ENSP00000356481 | P1 | |
NIBAN1 | ENST00000417056.5 | c.260+2751G>T | intron_variant | 3 | ENSP00000414039 | |||||
NIBAN1 | ENST00000487074.5 | n.1908G>T | non_coding_transcript_exon_variant | 9/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000141 AC: 35AN: 248114Hom.: 0 AF XY: 0.000186 AC XY: 25AN XY: 134390
GnomAD4 exome AF: 0.0000596 AC: 87AN: 1458694Hom.: 1 Cov.: 33 AF XY: 0.0000923 AC XY: 67AN XY: 725538
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.2436G>T (p.E812D) alteration is located in exon 14 (coding exon 14) of the FAM129A gene. This alteration results from a G to T substitution at nucleotide position 2436, causing the glutamic acid (E) at amino acid position 812 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at